GENELUX CORP - GNLX

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 12/20/2024 10:22:22 PM
EDGAR CIK 0001231457

Buy Breakdown

Total $0

Sell Breakdown

Total $95,722

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
12/16/2024
12/18/2024
Cappello Joseph
VP, Pharmaceutical Development
Officer
Sell
-6,300 @ $2.34
($14,742.00)
 14,653 (-30.07%) Direct
12/16/2024
12/18/2024
Smalling Ralph
Head of Regulatory
Officer
Sell
-2,510 @ $2.34
($5,873.40)
 16,322 (-13.33%) Direct
12/16/2024
12/18/2024
Zak Lourie S.
Chief Financial Officer
CFO
Sell
-2,103 @ $2.34
($4,921.02)
 40,802 (-4.90%) Direct
12/16/2024
12/18/2024
Zindrick Thomas
President and CEO
CEO Director
Sell
-14,315 @ $2.34
($33,497.10)
 37,372 (-27.70%) Direct
06/24/2024
07/08/2024
Jewett Caroline
Head of Quality
Officer
Sell
-4,961 @ $2.12
($10,517.32)
 16,174 (-23.47%) Direct
06/24/2024
07/08/2024
Ryder Sean
General Counsel
Officer
Sell
-5,496 @ $2.12
($11,651.52)
 19,388 (-22.09%) Direct
06/24/2024
07/08/2024
Yu Yong
VP, Clinical Trial Operations
Officer
Sell
-6,849 @ $2.12
($14,519.88)
 10,869 (-38.66%) Direct